Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 57.12 CNY -3.71%
Market Cap: 42.4B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Hangzhou Tigermed Consulting Co Ltd
Investor Relations

Founded in 2004, Hangzhou Tigermed Consulting Co., Ltd. emerged as a pivotal player in the flourishing landscape of clinical research services within the pharmaceutical and biotechnology sectors. As a leading contract research organization (CRO), Tigermed has meticulously woven a fabric of comprehensive solutions that span from drug development to clinical trial management. Their expertise extends across various therapeutic areas, underpinning a business model that thrives on facilitating the intricate process through which innovative drugs make their way from concept to market. The company’s robust portfolio of services encompasses clinical operations, regulatory submissions, data management, and biostatistics, effectively addressing the myriad needs of drug development companies looking to streamline operations and accelerate time-to-market.

Tigermed’s revenue model primarily revolves around contracts and partnerships with pharmaceutical and biotech companies seeking external expertise in clinical trials. The company's proficiency in managing multinational projects, especially within China and the broader Asia-Pacific region, provides an edge in a competitive global market that increasingly values speed and localized knowledge. Rather than merely providing traditional consulting services, Tigermed capitalizes on cutting-edge technology and a deep understanding of regional regulatory frameworks to offer a seamless and efficient trial process. In doing so, it captures the growing demand for outsourcing drug development work, ensuring steady revenue streams while solidifying its status as a vital partner in the relentless pursuit of medical innovation.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D.
Co-Founder & Chairman
No Bio Available
Dr. Xiaochun Cao M.D.
Co-Founder, GM & Executive Director
No Bio Available
Mr. Hao Wu
President & Executive Director
No Bio Available
Ms. Chengcheng Yang
Chief Financial Officer
No Bio Available
Mr. Zengyu Wen
Executive VP, COO & Executive Director
No Bio Available
Ms. Xiao Ri Li
Secretary
No Bio Available
Dr. Tianrong Ji M.D., Ph.D.
Chief Investment Officer
No Bio Available
Mr. Guoyun Yu
Head of Accounting Department
No Bio Available
Mr. Jiansong Yang Ph.D.
Senior VP & Chief Scientific Officer
No Bio Available
Mr. Alan Liu
Chief Compliance Officer
No Bio Available

Contacts

Address
ZHEJIANG
Hangzhou
20F, Block 8, No. 19, Jugong Road, Xixing Neighborhood, Binjiang District
Contacts
+8657189986795.0
www.tigermedgrp.com